IRVINE, Calif., Aug. 1, 2016/Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced they are in the final stages of escrow to transfer the 20-acre Northern California cultivation property into its name and commence indoor/outdoor cultivation and production on the land.
Tag Archives: Robert Kane
LOS ANGELES, Feb. 29, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS) continues to support top surgeon and CNN Medical Correspondent Dr. Sanjay Gupta for his historic and high profile work educating the U.S. and the world about the benefits of medical cannabis and support for the medical cannabis community.
COLORADO SPRINGS, Colo., Feb. 8, 2016/ Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced its next critical ailment target is autism and brings Mieko Hester-Perez on its Scientific Advisory Board to lead this charge.
BEVERLY HILLS, Calif., Aug. 1, 2014 /PRNewswire/ — Crown Baus Capital Corp. (OTC: CBCA), a global acquisition-based conglomerate targeting five primary industries: high-tech incubation, drug development, entertainment/media, education, and financial services, sees this week’s Congressional efforts to amend the Controlled Substances Act to permit medical use of cannabis on a nationwide basis as history in the making.
Cannabis Consulting INC. strives to link investors with the tools that they need in order to gain mass funding. The company also provides business solutions and consulting packages.